{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Acetylcholinesterase", "Bioisosterism", "Molecular docking", "Molecular dynamics", "Thiazolo[5,4-d]pyrimidinone"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38935303", "DateRevised": {"Year": "2024", "Month": "06", "Day": "27"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s11030-024-10920-x"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "27"}], "Journal": {"ISSN": "1573-501X", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Jun", "Day": "27"}}, "Title": "Molecular diversity", "ISOAbbreviation": "Mol Divers"}, "ArticleTitle": "Discovery of a novel pyrido[1,2-a]thiazolo[5,4-d]pyrimidinone derivatives with excellent potency against acetylcholinesterase.", "Abstract": {"AbstractText": ["As mimetic compounds of the natural alkaloid mackinazolinone, forty pyrido[1,2-a]thiazolo[5,4-d] pyrimidinone were designed and synthesized from a bioisosterism approach. The structure of these compounds was confirmed through analysis using <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS techniques. All the compounds were evaluated for their anticholinesterase activities and cytotoxicity on normal cells (293\u00a0T) by the Ellman method and methyl thiazolyl tetrazolium (MTT) method in vitro. and the structure-activity relationships (SARs) were summarized. The results showed that most of the compounds effectively inhibited acetylcholinesterase (AChE) in the micromolar range with weak cytotoxicity. Compound 7o exhibited the best inhibitory activity against AChE, displaying an IC<sub>50</sub> values of 1.67\u2009\u00b1\u20090.09\u00a0\u00b5M and an inhibitory constant K<sub>i</sub> of 11.31\u00a0\u00b5M as a competitive inhibitor to AChE. Molecular docking indicated that compound 7o may bind to AChE via hydrogen bond and \u03c0-\u03c0 stacking. Further molecular dynamics (MD) simulations indicated a relatively low binding free energy (-\u00a027.91\u00a0kJ\u00b7mol<sup>-1</sup>) of compound 7o with AChE. In summary, the collective findings suggested that 7o was promising as a potential novel drug candidate worthy of further investigation for the treatment of Alzheimer's disease."], "CopyrightInformation": "\u00a9 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Key Laboratory of Coal Mine Disaster Intelligent Prevention and Emergency Response, Xinjiang Institute of Engineering, Urumqi, 830023, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, 100049, China."}], "LastName": "Zeng", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Key Laboratory of Coal Mine Disaster Intelligent Prevention and Emergency Response, Xinjiang Institute of Engineering, Urumqi, 830023, China."}], "LastName": "Chen", "ForeName": "Zhifeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Key Laboratory of Coal Mine Disaster Intelligent Prevention and Emergency Response, Xinjiang Institute of Engineering, Urumqi, 830023, China."}], "LastName": "Yang", "ForeName": "Zhiyong", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Key Laboratory of Coal Mine Disaster Intelligent Prevention and Emergency Response, Xinjiang Institute of Engineering, Urumqi, 830023, China."}], "LastName": "Yuan", "ForeName": "Fangxue", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, China. nielf@ms.xjb.ac.cn."}], "LastName": "Nie", "ForeName": "Lifei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, China. niuchao@ms.xjb.ac.cn."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, 100049, China. niuchao@ms.xjb.ac.cn."}], "LastName": "Niu", "ForeName": "Chao", "Initials": "C"}], "GrantList": [{"GrantID": "2024XGYTCYC07", "Agency": "the Xinjiang Uygur Autonomous Region\"Tianchi Talent\"lntroduction Program", "Country": ""}, {"GrantID": "2022D01A340", "Agency": "the Natural Science Foundation of Xinjiang Uygur Autonomous Region", "Country": ""}, {"GrantID": "2022D01A339", "Agency": "the Natural Science Foundation of Xinjiang Uygur Autonomous Region", "Country": ""}, {"GrantID": "2023-XBQNXZ-009", "Agency": "West Light Foundation of the Chinese Academy of Sciences", "Country": ""}, {"GrantID": "2022D03018", "Agency": "Special Training Program of Natural Science Foundation of Xinjiang Autonomous Region", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Divers", "NlmUniqueID": "9516534", "ISSNLinking": "1381-1991"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Goedert M, Spillantini MG (2006) A century of alzheimer\u2019s disease. Science 314:777\u2013781. https://doi.org/10.1126/science.113281", "ArticleIdList": ["10.1126/science.113281", "17082447"]}, {"Citation": "Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G (2016) Therapies for prevention and treatment of alzheimer\u2019s Disease. BioMed Res Int. https://doi.org/10.1155/2016/2589276", "ArticleIdList": ["10.1155/2016/2589276", "27547756", "4980501"]}, {"Citation": "Prati F, Bottegoni G, Bolognesi ML, Cavalli A (2018) BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for alzheimer\u2019s disease. J Med Chem 61:619\u2013637. https://doi.org/10.1021/acs.jmedchem.7b00393", "ArticleIdList": ["10.1021/acs.jmedchem.7b00393", "28749667"]}, {"Citation": "Thompson PA, Wright DE, Counsell CE, Zajicek J (2012) Statistical analysis: trial design and duration in alzheimer\u2019s disease clinical trials: a review. Int Psychogeriatr 24:689\u2013697. https://doi.org/10.1017/s1041610211001116", "ArticleIdList": ["10.1017/s1041610211001116", "21910950"]}, {"Citation": "Citron M (2004) Strategies for disease modification in alzheimer\u2019s disease. Nat Rev Neurosci 5:677\u2013685. https://doi.org/10.1038/nrn1495", "ArticleIdList": ["10.1038/nrn1495", "15322526"]}, {"Citation": "Citron M (2010) Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov 9:387\u2013398. https://doi.org/10.1038/nrd2896", "ArticleIdList": ["10.1038/nrd2896", "20431570"]}, {"Citation": "Isacson O, Seo H, Lin L, Albeck D, Granholm AC (2002) Alzheimer\u2019s disease and Down\u2019s syndrome: roles of APP, trophic factors and Ach. Trends Neurosci 25:79\u201384. https://doi.org/10.1016/S0166-2236(02)02037-4", "ArticleIdList": ["10.1016/S0166-2236(02)02037-4", "11814559"]}, {"Citation": "Ittner LM, Goetz J (2011) Amyloid-beta and tau-a toxic pas de deux in alzheimer\u2019s disease. Nat Rev Neurosci 12:67\u201372. https://doi.org/10.1038/nrn2967", "ArticleIdList": ["10.1038/nrn2967"]}, {"Citation": "Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an alzheimer\u2019s disease mouse model. Science 316:750\u2013754. https://doi.org/10.1126/science.1141736", "ArticleIdList": ["10.1126/science.1141736", "17478722"]}, {"Citation": "Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in alzheimer\u2019s disease. Redox Biol 14:450\u2013464. https://doi.org/10.1016/j.redox.2017.10.014", "ArticleIdList": ["10.1016/j.redox.2017.10.014", "29080524"]}, {"Citation": "Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in alzheimer\u2019s disease. Lancet 308:1403\u20131403. https://doi.org/10.1016/S0140-6736(76)91936-X", "ArticleIdList": ["10.1016/S0140-6736(76)91936-X"]}, {"Citation": "Bartus RT, Dean R, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408\u2013414. https://doi.org/10.1126/science.7046051", "ArticleIdList": ["10.1126/science.7046051", "7046051"]}, {"Citation": "Augustinsson KB, Nachmansohn D (1949) Distinction between acetylcholine-esterase and other choline ester-splitting enzymes. Science 110:98\u201399. https://doi.org/10.1126/science.110.2847.98", "ArticleIdList": ["10.1126/science.110.2847.98", "17837670"]}, {"Citation": "Ferris SH (2003) Evaluation of memantine for the treatment of alzheimer\u2019s disease. Expert Opin Pharmacother 4:2305\u20132313. https://doi.org/10.1517/14656566.4.12.2305", "ArticleIdList": ["10.1517/14656566.4.12.2305", "14640929"]}, {"Citation": "Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206\u2013220. https://doi.org/10.1038/nrd1657", "ArticleIdList": ["10.1038/nrd1657", "15729362"]}, {"Citation": "Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461\u2013477. https://doi.org/10.1021/np068054v", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25:475\u2013516. https://doi.org/10.1039/B514294F", "ArticleIdList": ["10.1039/B514294F", "18497896"]}, {"Citation": "Li WH, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325:161\u2013165. https://doi.org/10.1126/science.1168243", "ArticleIdList": ["10.1126/science.1168243", "19589993"]}, {"Citation": "Ji HF, Li XJ, Zhang HY (2009) Natural products and drug discovery. EMBO Rep 10:194\u2013200. https://doi.org/10.1038/embor.2009.12", "ArticleIdList": ["10.1038/embor.2009.12", "19229284", "2658564"]}, {"Citation": "Breinbauer R, Vetter IR, Waldmann H (2002) From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. Angew Chem Int Ed 41:2878\u20132890. https://doi.org/10.1002/1521-3773(20020816)41:16%3c2878::aid-anie2878%3e3.0.co;2-b", "ArticleIdList": ["10.1002/1521-3773(20020816)41:16<2878::aid-anie2878>3.0.co;2-b"]}, {"Citation": "Ertl P, Roggo S, Schuffenhauer A (2007) Natural product-likeness score and its application for prioritization of compound libraries. J Chem Inf Model 48:68\u201374. https://doi.org/10.1021/ci700286x", "ArticleIdList": ["10.1021/ci700286x", "18034468"]}, {"Citation": "Horton DA, Bourne GT, Smythe ML (2003) The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 103:893\u2013930. https://doi.org/10.1021/cr020033s", "ArticleIdList": ["10.1021/cr020033s", "12630855"]}, {"Citation": "Connolly DJ, Cusack D, Osullivan TP, Guiry PJ (2005) Synthesis of quinazolinones and quinazolines. Tetrahedron 61:10153\u201310202. https://doi.org/10.1016/j.tet.2005.07.010", "ArticleIdList": ["10.1016/j.tet.2005.07.010"]}, {"Citation": "Fitagerald JS, Johns SR, Lamberton JA, Redcliffe AH (1966) 6,7,8,9-Tetrahydropyridoquinazolines, a new class of alkaloids from Mackinlaya species (Araliaceae). Aust J Chem 19:151\u2013159. https://doi.org/10.1071/CH9660151", "ArticleIdList": ["10.1071/CH9660151"]}, {"Citation": "Huang XF, Dong YH, Wang JH, Ke HM, Song GQ, Xu DF (2020) Novel PDE5 inhibitors derived from rutaecarpine for the treatment of alzheimer\u2019s disease. Bioorg Med Chem Lett. https://doi.org/10.1016/j.bmcl.2020.127097", "ArticleIdList": ["10.1016/j.bmcl.2020.127097", "33249134"]}, {"Citation": "Zeng Y, Nie LF, Bozorov K, Ruzi Z, Song B, Zhao JY, Aisa HA (2022) 2-Substituted tricyclic oxazolo[5,4-d]pyrimidine library: design, synthesis and cytotoxicity activity. J Heterocyclic Chemi 59:555\u2013568. https://doi.org/10.1002/jhet.4401", "ArticleIdList": ["10.1002/jhet.4401"]}, {"Citation": "Cabon G, Gaucher B, Gegout A, Heulle S, Masquelin T (2004) Novel solution and solid-phase syntheses of heterocyclic systems. Chimia 57:248\u2013254. https://doi.org/10.2533/000942903777679280", "ArticleIdList": ["10.2533/000942903777679280"]}, {"Citation": "Wang J, Cai P, Yang XL, Li F, Wu JJ, Kong LY, Wang XB (2017) Novel cinnamamide-dibenzylamine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for alzheimer\u2019s disease. Eur J Med Chem 139:68\u201383. https://doi.org/10.1016/j.ejmech.2017.07.077", "ArticleIdList": ["10.1016/j.ejmech.2017.07.077", "28800459"]}, {"Citation": "Li Q, Xing SS, Chen Y, Liao QH, Xiong BC, He SY, Lu WX, Liu Y, Yang HY, Li QH, Feng F, Liu WY, Chen Y, Sun HP (2020) Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor. J Med Chem 63:10030\u201310044. https://doi.org/10.1021/acs.jmedchem.0c01129", "ArticleIdList": ["10.1021/acs.jmedchem.0c01129", "32787113"]}, {"Citation": "Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci 90:9031\u20139035. https://doi.org/10.1073/pnas.90.19.903", "ArticleIdList": ["10.1073/pnas.90.19.903", "8415649", "47495"]}, {"Citation": "Hildebrand PW, Rose AS, Tiemann JKS (2019) Bringing molecular dynamics simulation data into view. Trends Biochem Sci 44:902. https://doi.org/10.1016/j.tibs.2019.06.004", "ArticleIdList": ["10.1016/j.tibs.2019.06.004", "31301982"]}, {"Citation": "Rasheed MA, Iqbal MN, Saddick S, Ali I, Khan FS, Kanwal S, Ahmed D, Ibrahim M, Afzal U, Awais M (2021) Identification of lead compounds against Scm (fms10) in Enterococcus faecium using computer aided drug designing. Life (Basel) 11:77. https://doi.org/10.3390/life11020077", "ArticleIdList": ["10.3390/life11020077", "33494233"]}, {"Citation": "Bozorov K, Zhao JY, Nie LF, Ma HR, Bobakulov K, Hu R, Rustamova N, Huang GZ, Efferth T, Aisa HA (2017) Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. part 2. RSC Adv 7:31417\u201331427. https://doi.org/10.1039/C7RA04808D", "ArticleIdList": ["10.1039/C7RA04808D"]}, {"Citation": "Hodges AJ, Matteucci M, Sharpe A, Sun MH, Wang XJ, Tsui VH (2013) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use. US2013/79321, A1."}, {"Citation": "Zhang C, Zhong B, Yang SM, Pan LK, Yu SW, Li ZJ, Li SC, Su B, Meng XB (2015) Synthesis and biological evaluation of thiabendazole derivatives as anti-angiogenesis and vascular disrupting agents. Bioorgan Med Chem 23:3774\u20133780. https://doi.org/10.1016/j.bmc.2015.03.085", "ArticleIdList": ["10.1016/j.bmc.2015.03.085"]}, {"Citation": "Nie LF, Bozorov K, Huang GZ, Zhao JY, Niu C, Aisa HA (2018) Design, synthesis, and toward a side-ring optimization of tricyclic thieno[2,3-d]pyrimidin-4(3H)-ones and their effect on melanin synthesis in murine B16 cells. Phosphorus Sulfur Silicon Relat Elem 193:656\u2013667. https://doi.org/10.1080/10426507.2018.1487968", "ArticleIdList": ["10.1080/10426507.2018.1487968"]}, {"Citation": "Sawa M, Moriyama H, Yamada T, Shitashige M, Kawase Y, Uno Y (2013) Novel bicyclic thiazole compounds. US2013/317218, A1."}, {"Citation": "Yao CL, Jiao B, Yang XL, Xu XB, Dang JS, Zhou GJ, Wu ZX, Lv XQ, Zeng Y, Wong WY (2013) Tris(cyclometalated) iridium(III) phosphorescent complexes with 2-phenylthiazole-type ligands: synthesis, photophysical, redox and electrophosphorescent behavior. Eur J Inorg Chem 27:4754\u20134763. https://doi.org/10.1002/ejic.201300595", "ArticleIdList": ["10.1002/ejic.201300595"]}, {"Citation": "Lee SY, Zheng XY, Krishnamoorthy J, Savelieff MG, Park HM, Brender JR, Kim HJ, Derrick JS, Kochi DA, Lee HJ (2014) Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of alzheimer\u2019s disease. JACS 136:299\u2013310. https://doi.org/10.1021/ja409801p", "ArticleIdList": ["10.1021/ja409801p"]}, {"Citation": "Mo J, Chen TK, Yang HY, Guo Y, Li Q, Qiao YT, Lin HZ, Feng F, Liu WY, Chen Y, Liu ZL, Sun HP (2020) Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against alzheimer\u2019s disease. J Enzym Inhib Med Ch 35:330\u2013343. https://doi.org/10.1080/14756366.2019.1699553", "ArticleIdList": ["10.1080/14756366.2019.1699553"]}, {"Citation": "Ruzi Z, Nie LF, Bozorov K, Zhao JY, Aisa HA (2021) Synthesis and anticancer activity of ethyl 5-aminol-N-substituted-imidazole-4-carboxylate building blocks. Arch Pharm. https://doi.org/10.1002/ardp.202000470", "ArticleIdList": ["10.1002/ardp.202000470"]}, {"Citation": "Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swamina S, Karplus M, Charmm M (1983) CHARMM: a program for macromolecular energy. J Comput Chem 4:187\u2013217. https://doi.org/10.1002/jcc.540040211", "ArticleIdList": ["10.1002/jcc.540040211"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "18"}, {"Year": "2024", "Month": "6", "Day": "17"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "12", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "12", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "11", "Minute": "13"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38935303", "10.1007/s11030-024-10920-x", "10.1007/s11030-024-10920-x"]}}]}